David T Rubin (David Rubin)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 93

Top Venues

Crohn's & colitis 360

Inflammatory bowel diseases

Digestive diseases and sciences

Journal of Crohn's & colitis

University of Chicago

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chicago

United States

Professor :: Medicine

Publications

Nathaniel A Cohen, Tenzin Choden, Emma C Dyer, Nicole M Garcia, Natalie K Choi, David T Rubin
Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center. Digestive diseases and sciences (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology 206 (1) (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology 206 (1) (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology (2024)
Nathaniel A Cohen, Tenzin Choden, Emma C Dyer, Nicole M Garcia, Natalie K Choi, David T Rubin
Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center. Digestive diseases and sciences (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology 206 (1) (2024)
Nathaniel A Cohen, Tenzin Choden, Emma C Dyer, Nicole M Garcia, Natalie K Choi, David T Rubin
Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center. Digestive diseases and sciences 69 (8) (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology 206 (1) (2024)
David T Rubin, Olga Kubassova, Christopher R Weber, Shashi Adsul, Marcelo Freire, Luc Biedermann, Viktor H Koelzer, Brian Bressler, Wei Xiong, Jan H Niess, Matthias S Matter, Uri Kopylov, Iris Barshack, Chen Mayer, Fernando Magro, Fatima Carneiro, Nitsan Maharshak, Ariel Greenberg, Simon Hart, Jamshid Dehmeshki, Laurent Peyrin-Biroulet
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis. Inflammatory bowel diseases (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology (2024)
Monica E W Derks, Maarten Te Groen, Lisa M A van Lierop, Sanjay Murthy, David T Rubin, Talat Bessissow, Iris D Nagtegaal, Willem A Bemelman, Lauranne A A P Derikx, Frank Hoentjen
Management of colorectal neoplasia in IBD patients: current practice and future perspectives. Journal of Crohn's & colitis (2024)
Bruce E Sands, Yvette Leung, David T Rubin, Krisztina B Gecse, Julian Panés, Martina Goetsch, Wenjin Wang, John C Woolcott, Christina C Smith, Karolina Wosik, Stefan Schreiber
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in UC: Analyses of the ELEVATE UC Clinical Programme. Journal of Crohn's & colitis (2024)
Michael W Mullowney, Aretha Fiebig, Matthew K Schnizlein, Mary McMillin, Amber R Rose, Jason Koval, David T Rubin, Sushila Dalal, Mitchell L Sogin, Eugene B Chang, Ashley M Sidebottom, Sean Crosson
Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of bacteriology 206 (1) (2024)
Shintaro Akiyama, Jacob E Ollech, Nathaniel A Cohen, Cindy Traboulsi, Victoria Rai, Laura R Glick, Yangtian Yi, Joseph Runde, Russell D Cohen, Kinga B Skowron Olortegui, Roger D Hurst, Konstantin Umanskiy, Benjamin D Shogan, Neil H Hyman, Michele A Rubin, Sushila R Dalal, Atsushi Sakuraba, Joel Pekow, Eugene B Chang, David T Rubin
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2024)
Nathaniel A Cohen, David Choi, Nicole Garcia, Natalie K Choi, Emma Picker, Noa Krugliak Cleveland, Russell D Cohen, Sushila R Dalal, Joel Pekow, David T Rubin
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center. Digestive diseases and sciences (2023)
Bruce E Sands, Stefan Schreiber, Irina Blumenstein, Michael V Chiorean, Ryan C Ungaro, David T Rubin
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis. Journal of Crohn's & colitis (2023)
David K Choi, David T Rubin, Archariya Puangampai, Monika Lach
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohn's & colitis 360 5 (2) (2023)
Yusuke Miyatani, David Choi, Natalie K Choi, David T Rubin
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Digestive diseases and sciences 69 (2) (2023)
Laurent Peyrin-Biroulet, Ethan Arenson, David T Rubin, Corey Allan Siegel, Scott Lee, F Stephen Laroux, Wen Zhou, Tricia Finney-Hayward, Yuri Sanchez Gonzalez, Alan L Shields
A comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: Geboes Score, Robarts Histopathology Index, and Nancy Index. Journal of Crohn's & colitis (2023)
Joseph Runde, Iva Veseli, Emily C Fogarty, Andrea R Watson, Quentin Clayssen, Mahmoud Yosef, Alon Shaiber, Ritu Verma, Christopher Quince, Konstantinos Gerasimidis, David T Rubin, A Murat Eren
Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease. Journal of Crohn's & colitis (2023)
Stefan Schreiber, David T Rubin, Siew C Ng, Laurent Peyrin-Biroulet, Silvio Danese, Irene Modesto, Xiang Guo, Chinyu Su, Kenneth K Kwok, Hyejin Jo, Yan Chen, Arne Yndestad, Walter Reinisch, Marla C Dubinsky
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. Journal of Crohn's & colitis (2023)
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, Harris A Ahmad, Shashi Adsul, Hilde Carlier, Marla Dubinsky, Matthew Germinaro, Vipul Jairath, Irene Modesto, Eric Mortensen, Neeraj Narula, Ezequiel Neimark, Alessandra Oortwijn, Marijana Protic, David T Rubin, Young S Oh, Jolanta Wichary, Laurent Peyrin-Biroulet, Walter Reinisch
Declining enrolment and other challenges in IBD clinical trials: Causes and potential solutions. Journal of Crohn's & colitis (2023)
Shintaro Akiyama, Nathaniel A Cohen, Maia Kayal, Marla C Dubinsky, Jean Frederic Colombel, David T Rubin
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. Inflammatory bowel diseases (2023)
Yusuke Miyatani, David Choi, Natalie K Choi, David T Rubin
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Digestive diseases and sciences 69 (2) (2023)
Silvio Danese, Remo Panaccione, Maria T Abreu, David T Rubin, Subrata Ghosh, Axel Dignass, Anita Afzali, Douglas C Wolf, Michael V Chiorean, Severine Vermeire, Anjali Jain, Lorna Charles, Garrett Lawlor, Mark T Osterman, Hsiuanlin Wu, James B Canavan, Ann Katrin Petersen, Jean Frederic Colombel, Miguel Regueiro
Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitis (2023)
Michael Todd Dolinger, Noa Krugliak Cleveland, David T Rubin, Marla C Dubinsky
Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States. The American journal of gastroenterology (2023)
David K Choi, David T Rubin, Archariya Puangampai, Monika Lach
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohn's & colitis 360 5 (2) (2023)
David K Choi, David T Rubin, Archariya Puangampai, Monika Lach
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohn's & colitis 360 5 (2) (2023)
Nathaniel A Cohen, Christopher R Weber, Jason X Cheng, David Choi, Nicole M Garcia, Natalie K Choi, David T Rubin
Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes. Journal of Crohn's & colitis (2023)
Yusuke Miyatani, David Choi, Natalie K Choi, David T Rubin
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Digestive diseases and sciences (2023)
Noa Krugliak Cleveland, Yusuke Miyatani, Emma A Picker, David T Rubin
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis. Inflammatory bowel diseases (2023)
Ferdinando D'Amico, Virginia Solitano, Fernando Magro, Pablo Andres Olivera, Jonas Halfvarson, David T Rubin, Axel Dignass, Sameer Al Awadhi, Taku Kobayashi, Natália Souza Freitas Queiroz, Marta Calvo, Paulo Gustavo Kotze, Subrata Ghosh, Laurent Peyrin-Biroulet, Silvio Danese
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. Journal of clinical medicine 12 (19) (2023)
David K Choi, David T Rubin, Archariya Puangampai, Monika Lach
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohn's & colitis 360 5 (2) (2023)
Pauline Wils, Vipul Jairath, Bruce E Sands, Fernando Magro, Walter Reinisch, David T Rubin, Silvio Danese, Cédric Baumann, Laurent Peyrin Biroulet
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease. United European gastroenterology journal (2023)
Timothy Raine, Yoh Ishiguro, David T Rubin, Tricia Finney-Hayward, Ramona Vladea, John Liu, Charles Phillips, Erica Cheng, Joseph W Windsor, Edward V Loftus
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme. Journal of Crohn's & colitis (2023)
Yaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, Todd Mackenzie, Damara J Crate, Joshua R Korzenik, Gil Y Melmed, Patricia Kozuch, Bruce E Sands, David T Rubin, Miguel D Regueiro, Raymond K Cross, Douglas C Wolf, John S Hanson, Ronald M Schwartz, Raluca Vrabie, Michael D Kreines, Timothy Scherer, Marla C Dubinsky, Corey A Siegel
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Alimentary pharmacology & therapeutics (2022)
David Fenton, Natalie K Choi, Nicole M Garcia, Emma C Dyer, Nathaniel A Cohen, David T Rubin
Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project. Crohn's & colitis 360 4 (4) (2022)
Nicole M Garcia, Nathaniel A Cohen, David T Rubin
Treat-to-target and sequencing therapies in Crohn's disease. United European gastroenterology journal 10 (10) (2022)
Shintaro Akiyama, Jacob E Ollech, Cindy Traboulsi, Victoria Rai, Laura R Glick, Yangtian Yi, Joseph Runde, Andrea D Olivas, Christopher R Weber, Russell D Cohen, Kinga B Skowron Olortegui, Roger D Hurst, Konstantin Umanskiy, Benjamin D Shogan, Michele A Rubin, Sushila R Dalal, Atsushi Sakuraba, Joel Pekow, Eugene B Chang, John Hart, Neil H Hyman, David T Rubin
Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis. Digestive diseases and sciences 67 (8) (2022)
Benjamin D McDonald, Emma C Dyer, David T Rubin
IL-23 Monoclonal Antibodies for IBD: So Many, So Different? Journal of Crohn's & colitis 16 (Supplement_2) (2022)
Frank I Scott, Orna Ehrlich, Dallas Wood, Catherine Viator, Carrie Rains, Lisa DiMartino, Jill McArdle, Gabrielle Adams, Lara Barkoff, Jennifer Caudle, Jianfeng Cheng, Jami Kinnucan, Kimberly Persley, Jennifer Sariego, Samir Shah, Caren Heller, David T Rubin
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation. Inflammatory bowel diseases (2022)
David K Choi, Archariya Puangampai, David T Rubin
Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease. The Annals of pharmacotherapy (2022)
Nicole M Garcia, Nathaniel A Cohen, David T Rubin
Treat-to-target and sequencing therapies in Crohn's disease. United European gastroenterology journal 10 (10) (2022)
David K Choi, David T Rubin, Archariya Puangampai, Noa Cleveland
Hypertensive Emergency After Initiating Ozanimod: A Case Report. Inflammatory bowel diseases 28 (8) (2022)
Britt Christensen, Ralley E Prentice, Aysha H Al-Ani, Eva Zhang, Alyse Bedell, David T Rubin
Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflammatory bowel diseases 28 (9) (2022)
Sasha R Fehily, Aysha H Al-Ani, Jonathan Abdelmalak, Clarissa Rentch, Eva Zhang, Justin T Denholm, Douglas Johnson, William K K Wu, Navneet Sharma, David T Rubin, Peter R Gibson, Britt Christensen
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management. Alimentary pharmacology & therapeutics 56 (1) (2022)
Adam E Mikolajczyk, Nathaniel A Cohen, Sydeaka Watson, Max Ackerman, Sarah R Goeppinger, John Hart, Jerrold R Turner, David T Rubin
Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis. Inflammatory bowel diseases (2022)
David Fenton, Natalie K Choi, Nicole M Garcia, Emma C Dyer, Nathaniel A Cohen, David T Rubin
Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project. Crohn's & colitis 360 4 (4) (2022)
Nathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, Cindy Traboulsi, Tina G Rodriguez, Jorie M Singer, Shivani Patel, Russell D Cohen, Sushila R Dalal, Atsushi Sakuraba, Joel Pekow, Dejan Micic, David T Rubin
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Digestive diseases and sciences (2022)
Nicole M Garcia, Nathaniel A Cohen, David T Rubin
Treat-to-target and sequencing therapies in Crohn's disease. United European gastroenterology journal (2022)
Anthony Buisson, Wing Yan Mak, Michael J Andersen, Donald Lei, Joel Pekow, Russell D Cohen, Stacy A Kahn, Bruno Pereira, David T Rubin
Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Inflammatory bowel diseases 27 (7) (2022)
Nicole M Garcia, Nathaniel A Cohen, David T Rubin
Treat-to-target and sequencing therapies in Crohn's disease. United European gastroenterology journal 10 (10) (2022)
Brian Bressler, Andres Yarur, Mark S Silverberg, Marielle Bassel, Emanuelle Bellaguarda, Chris Fourment, Anthie Gatopoulou, Pantelis Karatzas, Uri Kopylov, George Michalopoulos, Spyridon Michopoulos, Udayakumar Navaneethan, David T Rubin, Jesse Siffledeen, Andrew Singh, Konstantinos Soufleris, Dara Stein, Dirk Demuth, Gerassimos J Mantzaris
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. Journal of Crohn's & colitis 15 (10) (2022)
David T Rubin, Charles Sninsky, Britta Siegmund, Miquel Sans, Ailsa Hart, Brian Bressler, Yoram Bouhnik, Alessandro Armuzzi, Anita Afzali
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases 27 (12) (2022)
Scott Friedberg, Ira Hanan, Neil Hyman, Gustavo Rubio, Aarti Sharma, David T Rubin
Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection? Digestive diseases and sciences (2022)
Joseph Runde, Amarachi Erondu, Shintaro Akiyama, Cindy Traboulsi, Victoria Rai, Laura R Glick, Yangtian Yi, Jacob E Ollech, Russell D Cohen, Kinga B Skowron, Roger D Hurst, Konstatin Umanskiy, Benjamin D Shogan, Neil H Hyman, Michele A Rubin, Sushila R Dalal, Atsushi Sakuraba, Joel Pekow, Eugene B Chang, David T Rubin
Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis. Inflammatory bowel diseases 28 (9) (2022)
Nicole M Garcia, Nathaniel A Cohen, David T Rubin
Treat-to-target and sequencing therapies in Crohn's disease. United European gastroenterology journal 10 (10) (2022)
Cindy Traboulsi, Fares Ayoub, Alexa Silfen, Tina G Rodriguez, David T Rubin
Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center. Digestive diseases and sciences (2022)
David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies. Inflammatory bowel diseases 27 (8) (2022)
Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin
(Re)Appraising Remission in Ulcerative Colitis. Inflammatory bowel diseases (2022)
Dino Tarabar, Katia El Jurdi, Cindy Traboulsi, Olivia Yvellez, Zoran Milenkovic, Stanko Petrovic, Bojana Subotic, Ann Gils, Tanja Brocic, Irina Brcerevic, Olgica Latinovic, Tanja Jocic, David T Rubin
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab. Inflammatory bowel diseases 28 (10) (2022)
Corey Allan Siegel, Gil Y Melmed, Dermot Pb McGovern, Victoria Rai, Florian Krammer, David T Rubin, Maria T Abreu, Marla C Dubinsky, null null, null null
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut 70 (4) (2021)
Charles N Bernstein, Siew C Ng, Rupa Banerjee, Flavio Steinwurz, Bo Shen, Franck Carbonnel, Saeed Hamid, Ajit Sood, Jesus K Yamamoto-Furusho, Anne Griffiths, Eric I Benchimol, Simon Travis, Susana Lopes, David T Rubin, Gilaad G Kaplan, David Armstrong, Richard Gearry, null null
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflammatory bowel diseases 27 (6) (2021)
Seth R Shaffer, Amarachi I Erondu, Cindy Traboulsi, Victoria Rai, Noa Krugliak Cleveland, Amanda Israel, Britt Christensen, David T Rubin
Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia. Inflammatory bowel diseases (2021)
Maryam Zafer, Hui Zhang, Sujaata Dwadasi, Donald Goens, Raghavendra Paknikar, Sushila Dalal, Russell D Cohen, Joel Pekow, David T Rubin, Atsushi Sakuraba, Dejan Micic
A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohn's & colitis 360 4 (1) (2021)
Maryam Zafer, Hui Zhang, Sujaata Dwadasi, Donald Goens, Raghavendra Paknikar, Sushila Dalal, Russell D Cohen, Joel Pekow, David T Rubin, Atsushi Sakuraba, Dejan Micic
A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohn's & colitis 360 4 (1) (2021)
Seth R Shaffer, David T Rubin
Response to Tetangco and Hanauer. The American journal of gastroenterology 116 (9) (2021)
David T Rubin, Irene Modesto, Séverine Vermeire, Silvio Danese, William K K Wu, Kenneth K Kwok, Nana Koram, Thomas V Jones
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Alimentary pharmacology & therapeutics (2021)
Inessa Normatov, Daniela Fluxa, Jingzhou D Wang, Jacob E Ollech, George E Gulotta, Shivani Patel, Maria A Quintero, Bety De la Torre, Norma Solis, Oriana M Damas, Amar R Deshpande, David H Kerman, Maria T Abreu, David T Rubin
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction. Crohn's & colitis 360 3 (3) (2021)
Yangtian Yi, Philip H Sossenheimer, Amarachi I Erondu, Kinga B Skowron, Victoria Rai, Jorie M Singer, Katia El Jurdi, Neil H Hyman, David T Rubin
Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery. Digestive diseases and sciences (2021)
Shintaro Akiyama, Akihiro Yamada, Jacob E Ollech, Yuga Komaki, Fukiko Komaki, Joel Pekow, Sushila R Dalal, Russell D Cohen, David T Rubin, Atsushi Sakuraba
Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease. Journal of gastroenterology and hepatology 36 (10) (2021)
David T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, Swati Tole, Laura Sullivan, K T Park, Miguel Regueiro
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis. Crohn's & colitis 360 3 (4) (2021)
Séverine Vermeire, Chinyu Su, Nervin Lawendy, Taku Kobayashi, William J Sandborn, David T Rubin, Irene Modesto, Sean Gardiner, Nicole Kulisek, Haiying Zhang, Wenjin Wang, Julian Panés
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial. Journal of Crohn's & colitis 15 (7) (2021)
David T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, Swati Tole, Laura Sullivan, K T Park, Miguel Regueiro
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis. Crohn's & colitis 360 3 (4) (2021)
Simon J Hong, Noa Krugliak Cleveland, Shintaro Akiyama, Samantha Zullow, Yangtian Yi, Seth R Shaffer, Lisa B Malter, Jordan E Axelrad, Shannon Chang, David P Hudesman, David T Rubin
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States. Crohn's & colitis 360 3 (1) (2021)
Ashley M Sidebottom, Tina G Rodriguez, Jordan E Karpin, David T Rubin
Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease. Gastroenterology research and practice 2021 (2021)
Pablo A Olivera, Stéphane Zuily, Paulo Gustavo Kotze, Veronique Regnault, Sameer Al Awadhi, Peter Bossuyt, Richard B Gearry, Subrata Ghosh, Taku Kobayashi, Patrick Lacolley, Edouard Louis, Fernando Magro, William K K Wu, Alfredo Papa, Timothy Raine, Fabio V Teixeira, David T Rubin, Silvio Danese, Laurent Peyrin Biroulet
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology 18 (12) (2021)
Marla C Dubinsky, Iris Dotan, David T Rubin, Mark Bernauer, Dipen Patel, Raymond Cheung, Irene Modesto, Mark Latymer, Laurie Keefer
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert review of gastroenterology & hepatology 15 (9) (2021)
Inessa Normatov, Daniela Fluxa, Jingzhou D Wang, Jacob E Ollech, George E Gulotta, Shivani Patel, Maria A Quintero, Bety De la Torre, Norma Solis, Oriana M Damas, Amar R Deshpande, David H Kerman, Maria T Abreu, David T Rubin
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction. Crohn's & colitis 360 3 (3) (2021)
Simon J Hong, Noa Krugliak Cleveland, Shintaro Akiyama, Samantha Zullow, Yangtian Yi, Seth R Shaffer, Lisa B Malter, Jordan E Axelrad, Shannon Chang, David P Hudesman, David T Rubin
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States. Crohn's & colitis 360 3 (1) (2021)
Ajit Sood, Arshdeep Singh, Vandana Midha, Ramit Mahajan, Dina Kao, David T Rubin, Charles N Bernstein
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy. Crohn's & colitis 360 2 (4) (2020)
Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, Doug Johnson, Zaid S Ardalan, Neel M Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Finlay A Macrae, William K K Wu, David T Rubin, Britt Christensen
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Alimentary pharmacology & therapeutics 52 (1) (2020)
Thomas Greuter, Florian Rieder, Torsten Kucharzik, Laurent Peyrin Biroulet, Alain M Schoepfer, David T Rubin, Stephan R Vavricka
Emerging treatment options for extraintestinal manifestations in IBD. Gut 70 (4) (2020)
Edward V Loftus, Brian G Feagan, Remo Panaccione, Jean Frederic Colombel, William J Sandborn, Bruce E Sands, Silvio Danese, Geert R A M D'Haens, David T Rubin, Ira Shafran, Andrejus Parfionovas, Raquel Rogers, Richard A Lirio, Severine Vermeire
Long-term safety of vedolizumab for inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (8) (2020)
Ajit Sood, Arshdeep Singh, Vandana Midha, Ramit Mahajan, Dina Kao, David T Rubin, Charles N Bernstein
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy. Crohn's & colitis 360 2 (4) (2020)
Neeraj Narula, Achuthan Aruljothy, Abdul-Aziz Alshahrani, Ma'ayan Fadida, Mona Al-Saedi, John K Marshall, David T Rubin, Britt Christensen
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Adjoa Anyane-Yeboa, Betty Li, Cindy Traboulsi, Amarachi I Erondu, Philip Sossenheimer, Victoria Rai, David T Rubin
Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea. Digestive diseases and sciences 66 (7) (2020)
Jingzhou Wang, Joshua Prenner, Wenfei Wang, Atsushi Sakuraba, Neil Hyman, Sushila Dalal, Roger Hurst, Russell D Cohen, Konstantin Umanskiy, Benjamin D Shogan, Lindsay Alpert, David T Rubin, Janice Colwell, Joel Pekow
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 51 (12) (2020)
Jacob E Ollech, David T Rubin, Laura Glick, Roni Weisshof, Katia El Jurdi, Amanda Israel, Noa Krugliak Cleveland, Neil Hyman, Atsushi Sakuraba, Joel Pekow, Russell D Cohen, Sushila R Dalal
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Digestive diseases and sciences 64 (12) (2019)
Roni Weisshof, Maya Aharoni Golan, Philip H Sossenheimer, Katia El Jurdi, Jacob E Ollech, Joel Pekow, Russel D Cohen, Atsushi Sakuraba, Sushila Dalal, David T Rubin
Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Digestive diseases and sciences 64 (7) (2019)
Jacob E Ollech, Sujaata Dwadasi, Victoria Rai, Noam Peleg, Inessa Normatov, Amanda Israel, Philip H Sossenheimer, Britt Christensen, Joel Pekow, Sushila R Dalal, Atsushi Sakuraba, Russell D Cohen, David T Rubin
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Alimentary pharmacology & therapeutics 51 (6) (2019)
Haridarshan Patel, Trevor Lissoos, David T Rubin
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States. PloS one 12 (4) (2017)

David T Rubin.css-eqlu8i{font-size:small;padding-left:4px;} (David Rubin)

Publication Activity (10 Years)

Top Topics

Top Venues

David T Rubin (David Rubin)